ORICA LIMITED — Director's Dealing 2019

Nov 6, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity ORICA LIMITED ABN 24 004 145 868

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alberto Calderon
Date of last notice	11 January 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	4 November 2019 and 6 November 2019
No. of securities held prior to change	142,508 Ordinary Shares 613,806 Performance Rights
Class	1. Ordinary Shares 2. Performance Rights
Number acquired	1. 148,700 on 4 November 2019 2. Nil
Number disposed	1. 70,000 on 6 November 2019 2. 44,042 (on 4 November 2019)
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	1. $23.6490 2. $23.73
No. of securities held after change	221,208 Ordinary Shares 421,064 Performance Rights

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back

On 4 November 2019, 148,700 of the 192,742 Performance Rights granted to Dr Calderon pursuant to the FY2017 Orica Long Term Incentive Plan vested and were converted to ordinary shares at a price of $23.73. 44,042 Performance Rights were forfeited. On 6 November 2019, 70,000 ordinary shares were sold at a price of $23.6490, being the minimum amount required to be sold to cover Dr Calderon’s income tax liability on the FY2017 vested Performance Rights.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above No traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

Kirsten Gray Company Secretary 7 November 2019

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3